UK Oncology Forum

Dear Colleague

Unfortunately, the ACP has now had to cancel the Town Hall meeting, scheduled at the forthcoming UK Oncology Forum. The committee apologise for any inconvenience caused.

However – the UK Oncology Forum Faculty is excited to inform you that the meeting has been replaced with a new and very interesting Rapid Diagnostic Services Session, chaired by Dr Saoirse Dolly.

The UK Oncology forum is proud to showcase this inaugural meeting – highlighting the Rapid Diagnostic Services (RDS) for patients with non-site specific symptoms (NSS). Patients with NSS (such as weight loss, fatigue or pain) generally do not fit the standard two week rule (2WW) referral criteria and often bounce around systems and take longer to get diagnosed and treated.

Rapid Diagnostic Clinics (RDCs) provide a NSS 2WW referral route. These are being expanded across the Country with the aim of providing personalised, coordinated diagnostics to facilitate earlier cancer diagnosis and fast-track care. As well as reducing geographic differences in access to diagnostics. This session aims to bring primary care, diagnosticians, oncologists, radiologists and nurse practitioners together to share experiences in the development of the RDS and combine thinking on future developments and innovation.

Potential themes include:
1. RDS overview
RDC referral processes, filter function tests, pathway, alignment with cancer waiting times.
Clinical outcomes (present SEL RDC paper) with a focus on elderly, medically complex patients and mental health.
2. The RDS/re-direct
The vision – one referral, fluidity of care and improved patient journey. Process of re-directing patients between NSS and site specific (SS) pathways.
Options of front and back end redirects from other pathways
Present SEL data on volume of re-referrals from SS 2WW pathways and evaluation of the SEL lower GI back end pathway
Different models – ? involve greater manchester team where they use the upfront re-directs. Ernie on the AOS focused RDC model
3. Sustainability and service expansion
Overcoming health inequalities, NHSE typologies, workforce, financial effectiveness of the service
4. Innovation
Research opportunities, development, clinical trials

The session will take place Thursday 16th June 10:30hrs – 11:45hrs to register for the UK Oncology Forum (which has FREE registration and is CME accredited) please go to:
www.oncology-forum.co.uk/register

Best wishes
The UK Oncology Forum
PS please feel free to share with your colleagues

Latest News

By Clayton Wong on 23rd August 2025

Upcoming Webinar Series: Systematic Reviews & Covidence – Register Now!

BOPA is pleased to announce a new 3-part webinar series, delivered in collaboration with Covidence, to support members in understanding and engaging with systematic reviews in oncology pharmacy.   This…

Read article
By BOPA Executive Committee on 20th August 2025

Macmillan Cancer Support – We are always looking for Specialist Cancer pharmacists to join our review panel

Macmillan Cancer Support produces many cancer drug treatment pages. These page are widely used by healthcare professionals and people affected by cancer across the UK. We work hard to ensure…

Read article
By BOPA Executive Committee on 18th August 2025

BOPA 2025 Executive Committee Election – Its time to cast your vote!

Thank you to all of our nominees this year – we really appreciate your nominations for the Executive Committee.  Summary of nominations: In 2025 we received 4 nominations for 2…

Read article
By Joseph Williams on 15th August 2025

Celebrate World Pharmacist Day 2025 at The Royal Marsden!

The Royal Marsden invite BOPA members and colleagues to help us celebrate World Pharmacist Day on 25th September 2025 at an evening meeting. The meeting will include presentations from Dame…

Read article